Table 2 The diffusion-perfusion mismatch
From: Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials
MRI marker of the ischemic penumbra |
The strongest predictor of lesion growth from baseline |
Present in approximately 80% of MCA territory strokes up to 6 h |
poststroke |
Distinction of benign hypoperfusion from true tissue at risk not yet |
possible prospectively |